240 results
8-K
EX-10.2
f1m48rnjx6fcnwdhg er
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
EX-10.1
wt7lxnpbt31lwy3nc23
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
cal82fi7jb
1 Dec 22
Entry into a Material Definitive Agreement
9:23am
8-K
EX-99.1
4kbk81qy
14 Nov 22
TherapeuticsMD Announces Third Quarter 2022 Financial Results
4:24pm
8-K
EX-10.1
hc3zlyh
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-99.1
he247kbzbr6
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.1
vk5uh1v4yj9rnn7
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-99.1
b89ehgmasun
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-99.1
y1bfwua6htq p83bb
12 Sep 22
TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers
7:01am